Perceptive Advisors LLC Mei Pharma, Inc. Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.45 - $4.3 $4.39 Million - $13 Million	-3,030,440 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $2.27 Million - $7.73 Million	3,030,440 New	3,030,440 $4.88 Million
Q4 2019 Feb 14, 2020	SELL	$1.65 - $2.48 $7.26 Million - $10.9 Million	-4,400,440 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $4.1 $8.45 Million - $18 Million	4,400,440 New	4,400,440 $11.6 Million

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.